Microphysiometric Analysis of Human Alpha1a-adrenoceptor Expressed in Chinese Hamster Ovary Cells

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1999 Aug 5

PMID 10433504

Citations 12

Authors

T Taniguchi

R Inagaki

S Murata

I AKIBA

I Muramatsu

Affiliations

Soon will be listed here.

Abstract

1. The human recombinant alpha1a-adrenoceptor (AR) has been stably expressed in Chinese hamster ovary cells. Four stable clones, aH4, aH5, aH6 and aH7, expressing 30, 370, 940 and 2900 fmol AR mg(-1) protein, respectively, have been employed to characterize this AR subtype using radioligand binding and microphysiometry to measure extracellular acidification rates. 2. Noradrenaline (NA) gave concentration-dependent responses in microphysiometry with increasing extracellular acidification rates. The potency of NA increased as the receptor density increased; pEC50 values of NA for the clones aH4, aH5, aH6 and aH7 were 6.9, 7.5, 7.8 and 8.1, respectively. This increase of potency according to receptor density indicates the presence of spare receptor for NA. Methoxamine, phenylephrine, oxymetazoline and clonidine also gave concentration-dependent responses with various intrinsic activities. 3. Antagonists shifted concentration-response curves for NA rightward in a concentration-dependent manner. Schild analysis revealed that the affinity profile of this AR subtype to antagonists in the clone aH7 had a typical pattern for the alpha1a-AR; high affinity for prazosin and WB 4101, and low affinity for BMY7378 (pA2=9.5, 9.8 and 7.3, respectively). This profile is similar in the case of the clone aH4. These affinities were in good agreement with those obtained in binding experiments. 4. These results have demonstrated that (1) classical receptor theory can be applied in microphysiometry, and (2) microphysiometry is a useful tool to investigate the pharmacological characterization of alpha1a-AR.

Citing Articles

Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays.

Baker J, Summers R Handb Exp Pharmacol. 2024; 285:55-145.

PMID: 38926158 DOI: 10.1007/164_2024_713.

The human endogenous metabolome as a pharmacology baseline for drug discovery.

Bofill A, Jalencas X, Oprea T, Mestres J Drug Discov Today. 2019; 24(9):1806-1820.

PMID: 31226432 PMC: 7748399. DOI: 10.1016/j.drudis.2019.06.007.

Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.

Mitchell A, Hall R, Erickson S, Yates C, Lowery S, Hendrickson H Curr Eye Res. 2016; 41(12):1601-1607.

PMID: 27159349 PMC: 5209797. DOI: 10.3109/02713683.2015.1136419.

Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade.

Alexandre E, Kiguti L, Calmasini F, Silva F, da Silva K, Ferreira R Br J Pharmacol. 2015; 173(3):415-28.

PMID: 26493129 PMC: 4728418. DOI: 10.1111/bph.13367.

Phenotype pharmacology of lower urinary tract α(1)-adrenoceptors.

Nishimune A, Yoshiki H, Uwada J, Anisuzzaman A, Umada H, Muramatsu I Br J Pharmacol. 2011; 165(5):1226-34.

PMID: 21745191 PMC: 3372711. DOI: 10.1111/j.1476-5381.2011.01591.x.

References

Miller K, Owicki J, Sapolsky R . Effects of excitotoxin exposure on metabolic rate of primary hippocampal cultures: application of silicon microphysiometry to neurobiology. J Neurosci. 1992; 12(3):773-80. PMC: 6576048. View

Owicki J, Parce J, Kercso K, Sigal G, Muir V, Venter J . Continuous monitoring of receptor-mediated changes in the metabolic rates of living cells. Proc Natl Acad Sci U S A. 1990; 87(10):4007-11. PMC: 54033. DOI: 10.1073/pnas.87.10.4007. View

Minneman K, Theroux T, Hollinger S, Han C, Esbenshade T . Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol Pharmacol. 1994; 46(5):929-36. View

McKeithan T . Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci U S A. 1995; 92(11):5042-6. PMC: 41844. DOI: 10.1073/pnas.92.11.5042. View

MacEwan D, Kim G, Milligan G . Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor. Mol Pharmacol. 1995; 48(2):316-25. View

Horie K, Itoh H, Tsujimoto G . Hamster alpha 1B-adrenergic receptor directly activates Gs in the transfected Chinese hamster ovary cells. Mol Pharmacol. 1995; 48(3):392-400. View

Burt R, Chapple C, Marshall I . Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen. Br J Pharmacol. 1995; 115(3):467-75. PMC: 1908410. DOI: 10.1111/j.1476-5381.1995.tb16356.x. View

Perez D, Hwa J, Gaivin R, Mathur M, Brown F, Graham R . Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol. 1996; 49(1):112-22. View

Graham R, Perez D, Hwa J, Piascik M . alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res. 1996; 78(5):737-49. DOI: 10.1161/01.res.78.5.737. View

10.

Ong O, Dop C, Fung B . Real-time monitoring of reduced beta-adrenergic response in fibroblasts from patients with pseudohypoparathyroidism. Anal Biochem. 1996; 238(1):76-81. DOI: 10.1006/abio.1996.0254. View

11.

van der Graaf P, Shankley N, Black J . Analysis of the activity of alpha 1-adrenoceptor antagonists in rat aorta. Br J Pharmacol. 1996; 118(2):299-310. PMC: 1909637. DOI: 10.1111/j.1476-5381.1996.tb15403.x. View

12.

Trafton J, Tombaugh G, Yang S, Sapolsky R . Salutary and deleterious effects of acidity on an indirect measure of metabolic rate and ATP concentrations in CNS cultures. Brain Res. 1996; 731(1-2):122-31. DOI: 10.1016/0006-8993(96)00488-x. View

13.

Kenakin T . The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev. 1996; 48(3):413-63. View

14.

Theroux T, Esbenshade T, Peavy R, Minneman K . Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol. 1996; 50(5):1376-87. View

15.

Wakabayashi S, Shigekawa M, Pouyssegur J . Molecular physiology of vertebrate Na+/H+ exchangers. Physiol Rev. 1997; 77(1):51-74. DOI: 10.1152/physrev.1997.77.1.51. View

16.

Suzuki F, Miyamoto S, Takita M, Oshita M, Watanabe Y, Kakizuka A . Cloning, functional expression and tissue distribution of rabbit alpha 1d-adrenoceptor. Biochim Biophys Acta. 1997; 1323(1):6-11. DOI: 10.1016/s0005-2736(96)00229-5. View

17.

Ford A, Daniels D, Chang D, Gever J, Jasper J, Lesnick J . Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol. 1997; 121(6):1127-35. PMC: 1564783. DOI: 10.1038/sj.bjp.0701207. View

18.

Orlowski J, Grinstein S . Na+/H+ exchangers of mammalian cells. J Biol Chem. 1997; 272(36):22373-6. DOI: 10.1074/jbc.272.36.22373. View

19.

Muramatsu I, Murata S, Isaka M, Piao H, Zhu J, Suzuki F . Alpha1-adrenoceptor subtypes and two receptor systems in vascular tissues. Life Sci. 1998; 62(17-18):1461-5. DOI: 10.1016/s0024-3205(98)00090-3. View

20.

ARUNLAKSHANA O, SCHILD H . Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959; 14(1):48-58. PMC: 1481829. DOI: 10.1111/j.1476-5381.1959.tb00928.x. View